Sponsor or institution
Clinical trials and research at Glytr Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $3.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Maximizing a cancer immunotherapy that targets sugars on tumor cells
A new NIH grant supports advancing a cancer immunotherapy that uses special sugar-based targets to kill many solid tumors while aiming to spare normal cells.
-
Long‑lasting GlyTR1 with immune checkpoint drugs for solid cancers
This project tests whether a longer‑lasting version of GlyTR1 given with existing immune checkpoint medicines can help people with advanced, non‑resectable solid tumors.
-
New cancer treatment using extended half-life GlyTR1 with immune checkpoint inhibitors
This study is exploring a new way to help people with hard-to-treat cancers by using a special treatment that combines a new type of immune therapy with existing cancer treatments, aiming to better target and attack cancer cells for those who have limited options.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.